磷平衡计算器:血液透析患者高磷血症的个体化治疗工具
该多中心随机对照试验纳入119例维持性血液透析且血磷>1.45 mmol/L的患者,比较使用磷平衡计算器的个体化治疗与常规治疗4周后的效果。
要点
- 磷平衡计算器可改善维持性血液透析患者的血磷控制。
- 个体化组血磷达标率41%,显著高于常规组的18%。
- 血钙和PTH水平两组间无显著差异。
核心结论
- 磷平衡计算器可改善维持性血液透析患者的血磷控制,为管理高磷血症提供新工具。
研究设计与样本
- 随机、开放标签、多中心、4周临床试验,纳入119例年龄18-85岁、血清磷>1.45 mmol/L的维持性血液透析患者,来自上海三家大学教学医院,按1:1随机分为个体化治疗组(n=60)和常规治疗组(n=59)。
主要发现
- 血清钙、PTH水平及达标比例两组间无显著变化。
临床怎么用
- 对维持性血液透析高磷血症患者,可考虑使用磷平衡计算器制定个体化治疗方案以改善血磷控制。
局限性
- 研究为4周短期试验,开放标签设计,样本量119例,来自上海三家中心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lack of evaluations of the dietary phosphorus and dialysis phosphorus removal in daily clinical practice are common obstacles to assessing phosphorus balance and controlling phosphorus in hemodialysis patients. We aimed to investigate whether individualized therapy using a phosphorus balance calculator improves phosphorus control. METHODS: A randomized, open-label, multicenter, 4-week clinical trial was conducted. A total of 119 maintenance hemodialysis patients aged 18-85 years old and with serum phosphorus level >1.45 mmol/L from three university teaching hospitals in Shanghai were enrolled. Patients were randomized in a 1:1 ratio to individualized therapy (n = 60) or conventional therapy (n = 59). The primary outcome was the serum phosphorus concentration after 4-week treatment. Secondary outcomes included the serum calcium and parathyroid hormone (PTH) concentrations, changes in serum phosphorus, calcium and PTH concentrations, and the proportion of patients achieving target ranges of serum phosphorus, calcium and PTH after 4-week treatment. RESULTS: Among 119 randomized participants [mean age 62 years; 68 male (57%)], 116 completed the trial. Using the phosphorus balance calculator, the individualized group achieved a better phosphorus balance state and significantly reduced serum phosphorus (1.62 ± 0.45 mmol/L versus 1.85 ± 0.45 mmol/L, P = .006), increased the proportions of patients achieving target serum phosphorus range (41% versus 18%, P = .006) and had greater adjusted mean difference in change in serum phosphorus over the 4 weeks (-0.47 versus -0.23 mmol/L, P = .010) when compared with conventional therapy. No significant changes were observed in serum calcium and PTH levels, the proportion of patients achieving target serum calcium or PTH levels, or the adjusted mean difference of serum calcium and PTH levels over the treatment period. CONCLUSION: Phosphorus balance calculator was proved to improve serum phosphorus control in patients undergoing maintenance hemodialysis, offering a new tool for managing hyperphosphatemia.
引用
- Wang M, Xiao J, Du Q, et al. Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients. Nephrol Dial Transplant. 2024. PMID: 38037501. doi:10.1093/ndt/gfad256
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。